First, we interrogated the relative abundance of CD11b+ cell infiltrate into tumors 3 weeks after implantation of B16.F10 tumor cells and found that 2%–5% of the bulk tumor consisted of CD11b+ myeloid cells (S1 Fig). Here, ITGAM is linked to neoplasm.